MYC/BCL2 Co-Expression Is a Stronger Prognostic Factor Compared With the Cell-of-Origin Classification in Primary CNS DLBCL-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MYC/BCL2 Co-Expression Is a Stronger Prognostic Factor Compared With the Cell-of-Origin Classification in Primary CNS DLBCL

Published:2017-10-07 Issue:11 Volume:76 Page:942-948
ISSN:0022-3069
Container-title:Journal of Neuropathology & Experimental Neurology
language:en
Short-container-title:

Author:

Shi Qian-Yun,Feng Xiao,Bao Wei,Ma Jie,Lv Jing-Huan,Wang Xuan,Rao Qiu,Shi Qun-Li

Publisher

Oxford University Press (OUP)

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Neurology,General Medicine,Pathology and Forensic Medicine

Link

http://academic.oup.com/jnen/article-pdf/76/11/942/21283474/nlx083.pdf

Reference36 articles.

1. Primary CNS lymphoma;Expert Rev Anticancer Ther,2007

2. Targetable genetic features of primary testicular and primary central nervous system lymphomas;Blood,2016

3. Prognostic factors in primary central nervous system lymphomas;Hematol Oncol Clin North Am,2005

4. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling;Nature,2000

5. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma;N Engl J Med,2002

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Assessment in Patients With Primary Diffuse Large B‐Cell Lymphoma of the Central Nervous System Using MRI‐Based Radiomics;Journal of Magnetic Resonance Imaging;2024-07-06

2. The role of comorbidity indices and histochemical markers in surgically resected and non-resected primary central nervous system lymphoma;Clinical and Experimental Medicine;2023-07-25

3. Bruton’s tyrosine kinase inhibitors in the treatment of primary central nervous system lymphoma: A mini-review;Frontiers in Oncology;2022-11-17

4. Clinicopathological Characterization of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System;Anticancer Research;2022-10-26

5. Prognostic factors in primary central nervous system lymphoma;Current Opinion in Oncology;2022-09-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3